Maitake Extract References
  • Home

Maitake Extract Scientific References

Deng G, Lin H, Seidman A, Fornier M, D’Andrea G, Wesa K, Yeung S, Cunningham-Rundles S, Vickers AJ, Cassileth B (2009) A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects. J Cancer Res Clin Oncol 135:1215–1221

 Hishida, I., H. Nanba, and H. Kuroda. 1988. Antitumor activity exhibited by orally administered extract from fruit body of Grifola frondosa (maitake).Chem. Pharm. Bull. (Tokyo) 36:1819–1827.

 Harada, N., N. Kodama, and H. Nanba. 2003. Relationship between dendritic cells and the D-fraction-induced Th-1 dominant response in BALB/c tumor-bearing mice. Cancer Lett. 192:181–187.

Ito K, Masuda Y, Yamasaki Y, Yokota Y, Nanba H (2009) Maitake beta-glucan enhances granulopoiesis and mobilization of granulocytes by increasing G-CSF production and modulating CXCR4/SDF-1 expression. Int Immunopharmacol

Inoue, A., N. Kodama, and H. Nanba. 2002. Effect of maitake (Grifola frondosa) D-fraction on the control of the T lymph node Th-1/Th-2 proportion. Biol. Pharm. Bull. 25:536–540.

 Kodama N, Harada N, Nanba H. A polysaccharide, extract from Grifola frondosa, induces Th-1 dominant responses in carcinoma-bearing BALB/c mice. Jpn J Pharmacol 2002;90:357–60.

 Kodama N, Komuta K, Sakai N, Nanba H. Effects of D-Fraction, a polysaccharide from Grifola frondosa on tumor growth involve activation of NK cells. Biol Pharm Bull 2002;25:1647–50.

 Kodama, N., A. Asakawa, A. Inui, Y. Masuda, and H. Nanba. 2005. Enhancement of cytotoxicity of NK cells by D-fraction, a polysaccharide from Grifola frondosa. Oncol. Rep. 13:497–502.

 Kodama N, Murata Y, Asakawa A, Inui A, Hayashi M, Sakai N, et al. Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice. Nutrition 2005;21:624–9.

Lin, H., Y. H. She, B. R. Cassileth, F. Sirotnak, and S. Cunningham Rundles. 2004. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Int. Immunopharmacol. 4:91–99.

Lin H, She YH, Cassileth BR, Sirotnak F, Cunningham Rundles S (2004) Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Int Immunopharmacol 4:91–99

Lin H, Cheung SW, Nesin M, Cassileth BR, Cunningham-Rundles S (2007) Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production. Clin Vaccine Immunol 14:21–27

Lin H, De Stanchina E, Zhou XK, She YH, Hoang D, Cheung SW, Cassileth BR, Cunningham-Rundles S (2009) Maitake betaglucan enhances umbilical cord blood stem cell transplantation in the NOD/SCID mouse. Exp Biol Med (Maywood) 234:342–353

Masuda Y, Murata Y, Hayashi M, Nanba H. Inhibitory effect of MD-Fraction on tumor metastasis: involvement of NK cell activation and suppression of intercellular adhesionmolecule (ICAM)-1 expression in lung vascular endothelial cells. Biol Pharm Bull 2008;31(6):1104–8.

Masuda, Y., Ito, K., Konishi, M., Nanba, H. A polysaccharide extracted from Grifola frondosa enhances the anti-tumor activity of bone marrow-derived dendritic cell-based immunotherapy against murine colon cancer. Cancer Immunology, Immunotherapy 59 (10), pp. 1531-1541

Nanba, H., A. Hamaguchi, and H. Kuroda. 1987. The chemical structure of an antitumor polysaccharide in fruit bodies of Grifola frondosa (maitake). Chem. Pharm. Bull. (Tokyo) 35:1162–1168.

Nanba, H., and K. Kubo. December 1998. Antitumor substance extracted from grifola. U. S. patent 5,854,404. 25. Ohno, N., K. Saito, J. Nemoto, S. Kaneko,

Create a free website with Weebly